Form 4: Hartford Insurance Group EVP and CFO Beth Ann Costello Reports Stock Transactions
SEC Form 4 Filing
EVP and CFO of Hartford Insurance Group, Beth Ann Costello, reports the vesting and conversion of performance shares into common stock, along with details of existing stock options.
Summary
- On February 18, 2025, Beth Ann Costello, EVP and CFO of Hartford Insurance Group, reported transactions involving the company's stock.
- 34,364.988 performance shares were converted into common stock at a price of $0, based on the company's performance from January 1, 2022, through December 31, 2024.
- Following these transactions, Costello directly owns 103,533.606 shares of common stock.
- The report also details Costello's holdings of various stock options with exercise prices ranging from $48.89 to $95.74 and expiration dates extending to February 2034.
- These stock options represent the right to purchase a total of 573,993 shares of common stock.
Sentiment
Score: 6
Explanation: The document is a standard regulatory filing detailing stock transactions by a company executive. It doesn't contain overtly positive or negative information, but the vesting of performance shares suggests the company met certain performance goals.
Positives
- The vesting of performance shares indicates that the company met certain performance objectives during the period from January 1, 2022, to December 31, 2024.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. This filing indicates the vesting of performance-based compensation and provides a snapshot of the executive's holdings in the company.
Comparison to Industry Standards
- Comparing the vesting schedule and exercise prices of stock options to those of executives at peer companies like Allstate, Progressive, and Travelers could provide insights into the competitiveness of Hartford's compensation packages.
- The performance metrics used to determine the payout of performance shares can be benchmarked against industry best practices to assess their rigor and alignment with shareholder value creation.
Stakeholder Impact
- The vesting of performance shares and exercise of stock options can have a minor dilutive effect on existing shareholders.
- The transactions provide transparency to stakeholders regarding executive compensation and alignment with company performance.
Key Dates
| Date | Description |
|---|---|
| January 1, 2022 | Start date of the performance period for the performance shares. |
| February 28, 2020 | Date when stock options with an exercise price of $48.89 became fully exercisable. |
| February 26, 2022 | Date when stock options with an exercise price of $49.01 became fully exercisable. |
| February 23, 2024 | Date when stock options with an exercise price of $51.87 became fully exercisable. |
| February 28, 2024 | Date when one-third of the options with an exercise price of $78.28 became exercisable. |
| December 31, 2024 | End date of the performance period for the performance shares. |
| February 18, 2025 | Date of the reported transactions: conversion of performance shares to common stock. |
| February 23, 2025 | Date when the remaining one-third of the options with an exercise price of $69.41 will become exercisable. |
| February 27, 2025 | Date when one-third of the options with an exercise price of $95.74 will become exercisable. |
| February 28, 2025 | Date when an additional one-third of the options with an exercise price of $78.28 will become exercisable. |
| February 27, 2026 | Date when an additional one-third of the options with an exercise price of $95.74 will become exercisable. |
| February 28, 2026 | Date when the remaining one-third of the options with an exercise price of $78.28 will become exercisable. |
| February 28, 2027 | Expiration date for stock options with an exercise price of $48.89. |
| February 27, 2027 | Date when the remaining one-third of the options with an exercise price of $95.74 will become exercisable. |
| February 27, 2028 | Expiration date for stock options with an exercise price of $53.81. |
| February 26, 2029 | Expiration date for stock options with an exercise price of $49.01. |
| February 25, 2030 | Expiration date for stock options with an exercise price of $55.27. |
| February 23, 2031 | Expiration date for stock options with an exercise price of $51.87. |
| February 23, 2032 | Expiration date for stock options with an exercise price of $69.41. |
| February 28, 2033 | Expiration date for stock options with an exercise price of $78.28. |
| February 27, 2034 | Expiration date for stock options with an exercise price of $95.74. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.